Simple jQuery Dropdowns

Browsing by Author O. M. Bautista

Jump to: 0-9 A B C D E F G H I J K L M N O P Q R S T U V W X Y Z
or enter first few letters:  
Showing results 1 to 2 of 2
Issue DateTitleAuthor(s)
19-Feb-2014A 9-valent HPV vaccine against infection and intraepithelial neoplasia in womenE. A. Joura; A. R. Giuliano; O. E. Iversen; C. Bouchard; C. Mao; J. Mehlsen; E. D. Moreira; Y. Ngan; L. K. Petersen; E. Lazcano-Ponce; P. Pitisuttithum; J. A. Restrepo; G. Stuart; L. Woelber; Y. C. Yang; J. Cuzick; S. M. Garland; W. Huh; S. K. Kjaer; O. M. Bautista; I. S.F. Chan; J. Chen; R. Gesser; E. Moeller; M. Ritter; S. Vuocolo; A. Luxembourg; Medizinische Universitat Wien; Moffitt Cancer Center; Helse Bergen Haukeland University Hospital; Universite Laval; The University of British Columbia; University of Washington, Seattle; Kobenhavns Universitet; Rigshospitalet; Fundacao Oswaldo Cruz; The University of Hong Kong; Arhus Universitetshospital; Instituto Nacional de Salud Publica; Mahidol University; Investigación Clínica; Universitatsklinikum Hamburg-Eppendorf und Medizinische Fakultat; Mackay Memorial Hospital Taiwan; Barts and The London School of Medicine and Dentistry; University of Melbourne; University of Alabama; Merck & Co., Inc.
28-Jun-2011End-of-study safety, immunogenicity, and efficacy of quadrivalent HPV (types 6, 11, 16, 18) recombinant vaccine in adult women 24-45 years of ageX. Castellsagué; N. Mũoz; P. Pitisuttithum; D. Ferris; J. Monsonego; K. Ault; J. Luna; E. Myers; S. Mallary; O. M. Bautista; J. Bryan; S. Vuocolo; R. M. Haupt; A. Saah; Institut d'Investigacio Biomedica de Bellvitge; National Institute of Cancer; Mahidol University; Medical College of Georgia; Department of Cyto-colposcopy; Emory University School of Medicine; Duke University School of Medicine; Merck & Co., Inc.